136 related articles for article (PubMed ID: 2189258)
21. Immunogenicity testing of a novel engineered HIV-1 envelope gp140 DNA vaccine construct.
Kumar S; Yan J; Muthumani K; Ramanathan MP; Yoon H; Pavlakis GN; Felber BK; Sidhu M; Boyer JD; Weiner DB
DNA Cell Biol; 2006 Jul; 25(7):383-92. PubMed ID: 16848679
[TBL] [Abstract][Full Text] [Related]
22. Structural properties of HIV-1 Env fused with the 14-kDa vaccinia virus envelope protein.
Rodriguez JR; Rodriguez D; Esteban M
Virology; 1991 Apr; 181(2):742-8. PubMed ID: 2014647
[TBL] [Abstract][Full Text] [Related]
23. Glycosylation-dependent peptide antigenic determinants of env gp46 HTLV-1.
Kaumaya PT; Conrad SF; DiGeorge AM; Lairmore MD
Leukemia; 1995 Oct; 9 Suppl 1():S133-8. PubMed ID: 7475306
[TBL] [Abstract][Full Text] [Related]
24. Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino-terminal signal sequence.
McChesney M; Tanneau F; Regnault A; Sansonetti P; Montagnier L; Kieny MP; Rivière Y
Eur J Immunol; 1990 Jan; 20(1):215-20. PubMed ID: 2106442
[TBL] [Abstract][Full Text] [Related]
25. Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene.
Ibuki K; Funahashi SI; Yamamoto H; Nakamura M; Igarashi T; Miura T; Ido E; Hayami M; Shida H
J Gen Virol; 1997 Jan; 78 ( Pt 1)():147-52. PubMed ID: 9010298
[TBL] [Abstract][Full Text] [Related]
26. IL-12 delivery from recombinant vaccinia virus attenuates the vector and enhances the cellular immune response against HIV-1 Env in a dose-dependent manner.
Gherardi MM; Ramirez JC; Rodríguez D; Rodríguez JR; Sano G; Zavala F; Esteban M
J Immunol; 1999 Jun; 162(11):6724-33. PubMed ID: 10352291
[TBL] [Abstract][Full Text] [Related]
27. Control of Human T-Cell Leukemia Virus Type 1 (HTLV-1) Infection by Eliminating Envelope Protein-Positive Cells with Recombinant Vesicular Stomatitis Viruses Encoding HTLV-1 Primary Receptor.
Tezuka K; Okuma K; Kuramitsu M; Matsuoka S; Tanaka R; Tanaka Y; Hamaguchi I
J Virol; 2018 Feb; 92(4):. PubMed ID: 29212930
[TBL] [Abstract][Full Text] [Related]
28. Syncytium formation by recombinant HTLV-II envelope glycoprotein.
Li QX; Camerini D; Xie Y; Greenwald M; Kuritzkes DR; Chen IS
Virology; 1996 Apr; 218(1):279-84. PubMed ID: 8615036
[TBL] [Abstract][Full Text] [Related]
29. Mammalian cell/vaccinia virus expression vectors with increased stability of retroviral sequences in Escherichia coli: production of feline immunodeficiency virus envelope protein.
Wang RF; Mullins JI
Gene; 1995 Feb; 153(2):197-202. PubMed ID: 7875588
[TBL] [Abstract][Full Text] [Related]
30. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
[TBL] [Abstract][Full Text] [Related]
31. Immune response to caprine arthritis-encephalitis virus surface protein induced by coimmunization with recombinant vaccinia viruses expressing the caprine arthritis-encephalitis virus envelope gene and caprine interleukin-12.
Cheevers WP; Hötzel I; Beyer JC; Kumpula-McWhirter N
Vaccine; 2000 May; 18(23):2494-503. PubMed ID: 10775783
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus).
Kazanji M; Tartaglia J; Franchini G; de Thoisy B; Talarmin A; Contamin H; Gessain A; de Thé G
J Virol; 2001 Jul; 75(13):5939-48. PubMed ID: 11390595
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the expression and immunogenicity of poliovirus replicons that encode simian immunodeficiency virus SIVmac239 Gag or envelope SU proteins.
Anderson MJ; Porter DC; Moldoveanu Z; Fletcher TM; McPherson S; Morrow CD
AIDS Res Hum Retroviruses; 1997 Jan; 13(1):53-62. PubMed ID: 8989427
[TBL] [Abstract][Full Text] [Related]
34. Removal of cryptic poxvirus transcription termination signals from the human immunodeficiency virus type 1 envelope gene enhances expression and immunogenicity of a recombinant vaccinia virus.
Earl PL; Hügin AW; Moss B
J Virol; 1990 May; 64(5):2448-51. PubMed ID: 2182912
[TBL] [Abstract][Full Text] [Related]
35. Expression of bovine leukaemia virus envelope gene by recombinant vaccinia viruses.
Kumar S; Andrew ME; Boyle DB; Brandon RB; Lavin MF; Daniel RC
Virus Res; 1990 Oct; 17(2):131-42. PubMed ID: 1963249
[TBL] [Abstract][Full Text] [Related]
36. High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants.
Chanda PK; Natuk RJ; Mason BB; Bhat BM; Greenberg L; Dheer SK; Molnar-Kimber KL; Mizutani S; Lubeck MD; Davis AR
Virology; 1990 Apr; 175(2):535-47. PubMed ID: 2183470
[TBL] [Abstract][Full Text] [Related]
37. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay.
Okuma K; Nakamura M; Nakano S; Niho Y; Matsuura Y
Virology; 1999 Feb; 254(2):235-44. PubMed ID: 9986790
[TBL] [Abstract][Full Text] [Related]
38. [Combination immunization with EIAV Env protein expressed by recombinant baculovirus and recombinant vaccinia virus containing env gene].
Dai CM; Zhang XY; Zhang RR; Shao YM; Shen RX
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Jul; 20(4):410-4. PubMed ID: 15207082
[TBL] [Abstract][Full Text] [Related]
39. Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130.
Voss G; Dittmer U; Coulibaly C; Makoschey B; Petry H; Lüke W; Hunsmann G
J Gen Virol; 1993 Sep; 74 ( Pt 9)():1757-63. PubMed ID: 8376957
[TBL] [Abstract][Full Text] [Related]
40. Evidence for autoantigens of Env/Tax proteins in human T cell leukemia virus type I Env-pX transgenic mice.
Fujisawa K; Okamoto K; Asahara H; Hasunuma T; Kobata T; Kato T; Sumida T; Nishioka K
Arthritis Rheum; 1998 Jan; 41(1):101-9. PubMed ID: 9433875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
